Skip to content
20-F

Annual Report (Foreign)

Innate Pharma SA IPHA IPHYF

0001598599-26-000005

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 89.59M sh
Shares Diluted FY 2025 · Dec 31, 2024 81.05M sh
Shares Diluted FY 2025 · Dec 31, 2023 80.45M sh
Shares Outstanding FY 2025 · Dec 31, 2025 93.72M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −€52.76M
Operating Cash Flow FY 2025 · Dec 31, 2024 −€6.9M
Operating Cash Flow restated FY 2025 · Dec 31, 2023 −€32.56M
Cash And Equivalents FY 2025 · Dec 31, 2025 €28.09M
Cash And Equivalents FY 2025 · Dec 31, 2024 €66.4M
Cash And Equivalents FY 2025 · Dec 31, 2023 €70.61M
Cash And Equivalents FY 2025 · Dec 31, 2022 €84.23M
Stockholders Equity FY 2025 · Dec 31, 2025 −€21.7M
Stockholders Equity FY 2025 · Dec 31, 2024 €8.83M
Stockholders Equity FY 2025 · Dec 31, 2023 €51.9M
Stockholders Equity FY 2025 · Dec 31, 2022 €54.15M
Current Liabilities FY 2025 · Dec 31, 2025 €36.65M
Current Liabilities FY 2025 · Dec 31, 2024 €32.98M
Current Liabilities restated FY 2025 · Dec 31, 2023 €39.64M
Current Assets FY 2025 · Dec 31, 2025 €46.71M
Current Assets FY 2025 · Dec 31, 2024 €85.74M
Current Assets restated FY 2025 · Dec 31, 2023 €148.01M
Total Assets FY 2025 · Dec 31, 2025 €62.72M
Total Assets FY 2025 · Dec 31, 2024 €111.06M
Total Assets restated FY 2025 · Dec 31, 2023 €175.19M
Eps Diluted FY 2025 · Dec 31, 2025 −€0.55
Eps Diluted FY 2025 · Dec 31, 2024 −€0.61
Eps Diluted FY 2025 · Dec 31, 2023 −€0.09
Eps Basic FY 2025 · Dec 31, 2025 −€0.55
Eps Basic FY 2025 · Dec 31, 2024 −€0.61
Eps Basic FY 2025 · Dec 31, 2023 −€0.09
Rd Expense FY 2025 · Dec 31, 2025 €43.62M
Rd Expense FY 2025 · Dec 31, 2024 €51.98M
Rd Expense FY 2025 · Dec 31, 2023 €56.02M
Net Income FY 2025 · Dec 31, 2025 −€49.18M
Net Income FY 2025 · Dec 31, 2024 −€49.47M
Net Income FY 2025 · Dec 31, 2023 −€7.57M
Operating Income FY 2025 · Dec 31, 2025 −€54.01M
Operating Income FY 2025 · Dec 31, 2024 −€51.58M
Operating Income FY 2025 · Dec 31, 2023 −€12.67M
Revenue FY 2025 · Dec 31, 2025 €9.01M
Revenue FY 2025 · Dec 31, 2024 €20.12M
Revenue FY 2025 · Dec 31, 2023 €61.64M